TheraRadar
← Back
Data updated: Mar 29, 2026

RUBICON

Pharmaceuticals
Generics

RUBICON is a generic drug manufacturer with 5 FDA-approved products.

2022
Since
5
Drugs
-
Trials
27
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
CLOMIPHENE CITRATE 2025-12-18
Labeling
FLUTICASONE PROPIONATE 2025-12-16
Manufacturing (CMC)
CLOMIPHENE CITRATE 2025-10-17
CHLORPROMAZINE HYDROCHLORIDE 2025-10-10
CLOMIPHENE CITRATE 2025-10-03
FLUTICASONE PROPIONATE 2025-08-15
FLUTICASONE PROPIONATE 2025-07-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...